Roberto Saporetti
Research Subjects
Roberto Saporetti has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Alberto Danielli
Dipartimento di Farmacia e Biotecnologie Alma Mater Studiorum – Università di Bologna Bologna Italy
4 shared publications - Matteo Calvaresi
University of Bologna
4 shared publications - Luca Ulfo
Dipartimento di Farmacia e Biotecnologie, Alma Mater Studiorum—Università di Bologna, Via Francesco Selmi 3, 40126 Bologna, Italy
3 shared publications - Matteo Di Giosia
Department of Chemistry “Giacomo Ciamician” Alma Mater Studiorum ‐ University of Bologna Bologna Italy
3 shared publications - Paolo Emidio Costantini
Dipartimento di Farmacia e Biotecnologie Alma Mater Studiorum – Università di Bologna Bologna Italy
3 shared publications Andrea Cantelli
Dipartimento di Chimica "G. Ciamician", Alma Mater Studiorum - Università di Bologna, Bologna, Italy
2 shared publications
Latest Publications
- Open Access
Differential translocation of bacteriophages across the intestinal barrier in health and Crohn’s disease
SUMMARY: Impaired intestinal barrier function is a major feature of Crohn’s disease (CD), leading to exacerbated inflammation in response to the microbiota. In this context, the translocation of intestinal bacteriophages (phages) and their effects on the host have been little investigated. We used phage fluorescence imaging coupled with ex-vivo and in-vitro models that mimic physiological and inflammatory conditions and found that phages can translocate across the intestinal barrier without disrupting its integrity. Although the translocation rate across the intestinal epithelium depended on phage morphology and the condition of the barrier, these factors did not influence the crossing of phage across the vascular endothelium. Virome analysis confirmed that viral sequences shared between blood and stool samples are more abundant in CD patients than healthy subjects, indicating that a barrier defect facilitates phage translocation from the gut to the bloodstream.
Open AccessDifferential translocation of bacteriophages across the intestinal barrier in health and Crohn’s disease
SUMMARY: Impaired intestinal barrier function is a major feature of Crohn’s disease (CD), leading to exacerbated inflammation in response to the microbiota. In this context, the translocation of intestinal bacteriophages (phages) and their effects on the host have been little investigated. We used phage fluorescence imaging coupled with ex-vivo and in-vitro models that mimic physiological and inflammatory conditions and found that phages can translocate across the intestinal barrier without disrupting its integrity. Although the translocation rate across the intestinal epithelium depended on phage morphology and the condition of the barrier, these factors did not influence the crossing of phage across the vascular endothelium. Virome analysis confirmed that viral sequences shared between blood and stool samples are more abundant in CD patients than healthy subjects, indicating that a barrier defect facilitates phage translocation from the gut to the bloodstream.
- Open Access
- 1 February 2022
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 179, 242-251
Advanced photodynamic therapy with an engineered M13 phage targeting EGFR: Mitochondrial localization and autophagy induction in ovarian cancer cell lines
- 1 February 2022
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 179, 242-251
Open AccessAdvanced photodynamic therapy with an engineered M13 phage targeting EGFR: Mitochondrial localization and autophagy induction in ovarian cancer cell lines
- 12 November 2021
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 14 (3) , 632-641
Orthogonal nanoarchitectonics of M13 phage for receptor targeted anticancer photodynamic therapy
Not all viruses are bad . We developed an orthogonal approach (genetic/chemical) to engineer M13 bacteriophages as targeted vectors for efficient photodynamic killing of cancer cells.
- 12 November 2021
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 14 (3) , 632-641
Orthogonal nanoarchitectonics of M13 phage for receptor targeted anticancer photodynamic therapy
Not all viruses are bad . We developed an orthogonal approach (genetic/chemical) to engineer M13 bacteriophages as targeted vectors for efficient photodynamic killing of cancer cells.
- Open Access
- 18 June 2021
- Published by MDPI AG in Nanomaterials
- Vol. 11 (6) , 1608
Spiky Gold Nanoparticles for the Photothermal Eradication of Colon Cancer Cells
Colorectal cancer (CRC) is a widespread and lethal disease. Relapses of the disease and metastasis are very common in instances of CRC, so adjuvant therapies have a crucial role in its treatment. Systemic toxic effects and the development of resistance during therapy limit the long-term efficacy of existing adjuvant therapeutic approaches. Consequently, the search for alternative strategies is necessary. Photothermal therapy (PTT) represents an innovative treatment for cancer with great potential. Here, we synthesize branched gold nanoparticles (BGNPs) as attractive agents for the photothermal eradication of colon cancer cells. By controlling the NP growth process, large absorption in the first NIR biological window was obtained. The FBS dispersed BGNPs are stable in physiological-like environments and show an extremely efficient light-to-heat conversion capability when irradiated with an 808-nm laser. Sequential cycles of heating and cooling do not affect the BGNP stability. The uptake of BGNPs in colon cancer cells was confirmed using flow cytometry and confocal microscopy, exploiting their intrinsic optical properties. In dark conditions, BGNPs are fully biocompatible and do not compromise cell viability, while an almost complete eradication of colon cancer cells was observed upon incubation with BGNPs and irradiation with an 808-nm laser source. The PTT treatment is characterized by an extremely rapid onset of action that leads to cell membrane rupture by induced hyperthermia, which is the trigger that promotes cancer cell death.
- 18 June 2021
- Published by MDPI AG in Nanomaterials
- Vol. 11 (6) , 1608
Open AccessSpiky Gold Nanoparticles for the Photothermal Eradication of Colon Cancer Cells
Colorectal cancer (CRC) is a widespread and lethal disease. Relapses of the disease and metastasis are very common in instances of CRC, so adjuvant therapies have a crucial role in its treatment. Systemic toxic effects and the development of resistance during therapy limit the long-term efficacy of existing adjuvant therapeutic approaches. Consequently, the search for alternative strategies is necessary. Photothermal therapy (PTT) represents an innovative treatment for cancer with great potential. Here, we synthesize branched gold nanoparticles (BGNPs) as attractive agents for the photothermal eradication of colon cancer cells. By controlling the NP growth process, large absorption in the first NIR biological window was obtained. The FBS dispersed BGNPs are stable in physiological-like environments and show an extremely efficient light-to-heat conversion capability when irradiated with an 808-nm laser. Sequential cycles of heating and cooling do not affect the BGNP stability. The uptake of BGNPs in colon cancer cells was confirmed using flow cytometry and confocal microscopy, exploiting their intrinsic optical properties. In dark conditions, BGNPs are fully biocompatible and do not compromise cell viability, while an almost complete eradication of colon cancer cells was observed upon incubation with BGNPs and irradiation with an 808-nm laser source. The PTT treatment is characterized by an extremely rapid onset of action that leads to cell membrane rupture by induced hyperthermia, which is the trigger that promotes cancer cell death.